(Q44151337)

30 November 2017

title

In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials (English)

1 reference

30 November 2017

main subject

multiple drug resistance

1 reference

inferred from title

Streptococcus pneumoniae

1 reference

Nicholaus J Hilliard

1

1 reference

30 November 2017

Crystal N Johnson

2

1 reference

30 November 2017

Sarah H Armstrong

3

1 reference

30 November 2017

Stephanie Quarles

4

1 reference

30 November 2017

Ken B Waites

5

1 reference

30 November 2017

publication date

1 August 2002

1 reference

International Journal of Antimicrobial Agents

30 November 2017

published in

1 reference

30 November 2017

volume

20

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

136-140

1 reference

Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900129-2

7 January 2021

In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900129-2

7 January 2021

Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900129-2

7 January 2021

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900129-2

7 January 2021

In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900129-2

7 January 2021

Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900129-2

7 January 2021

In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900129-2

7 January 2021

10.1016/S0924-8579(02)00129-2

Identifiers

DOI

1 reference

30 November 2017

1 reference